The volume of foreign investment in the production of pharmaceutical products in Ukraine is estimated to be at least several hundred million dollars, according to the Ministry of Economy of Ukraine. It is noted that from 2016 to 2021, the volume of capital investments in the industry grew steadily from $65M to $106M.
The Ministry of Economy emphasized that the Russian invasion provoked a sharp drop in the production and sales of pharmaceutical products, but the industry has still grown by more than 27% during the war. The Ministry of Economy considers the production of mRNA vaccines and the development of artificial intelligence research tools to be promising areas for investment, as well as the increased demand for drugs that treat chronic diseases and support mental health.
At URC2024, Ukrainian pharmaceutical company Darnytsia announced its intention to attract $270M in debt financing to establish the production of its own mRNA vaccines and $108M to produce raw pharmaceutical materials.